Publication | Open Access
Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer
378
Citations
40
References
2016
Year
Clinically informative genomic profiling of cfDNA was feasible in nearly all patients with mCRPC and can provide important insights into enzalutamide response and resistance.
| Year | Citations | |
|---|---|---|
Page 1
Page 1